Further Observations on the Growth of Mouse Mammary Carcinomata in the Strain of Origin
1964

Growth of Mouse Mammary Tumors and Immune Response

Sample size: 12 publication Evidence: moderate

Author Information

Author(s): M. O. Symes

Primary Institution: University of Bristol

Hypothesis

The deletion of tumor-specific antigens is a characteristic of progressive malignant growth.

Conclusion

Tumors grown in hosts with depressed immune function showed slower growth and a more persistent immune response.

Supporting Evidence

  • Both tumor lines showed increased lymph node and spleen weights in early passages.
  • The Melphalan line tumors grew more slowly than the normal line tumors.
  • Immunological stimulation was initially present but diminished with more passages.

Takeaway

When mice with tumors are treated with a drug that weakens their immune system, the tumors grow more slowly and the immune system keeps responding longer.

Methodology

Two types of mouse mammary tumors were transplanted into untreated mice and mice treated with Melphalan, and their growth rates and immune responses were compared.

Limitations

The results from spontaneous tumors are not directly comparable to those from subsequent passages due to differing time frames.

Participant Demographics

Highly inbred A-strain mice of both sexes.

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication